Resultados globales: 3 registros encontrados en 0.02 segundos.
Artículos, Encontrados 3 registros
Artículos Encontrados 3 registros  
1.
20 p, 1.3 MB Early prognostic performance of miR155-5p monitoring for the risk of rejection : Logistic regression with a population pharmacokinetic approach in adult kidney transplant patients / Quintairos, Luis (Hospital Clínic i Provincial de Barcelona) ; Colom, Helena (Universitat de Barcelona. Departament de Farmacologia, Toxicologia i Química Terapèutica) ; Millan, Olga (Instituto de Salud Carlos III) ; Fortuna, Virginia (Hospital Clínic i Provincial de Barcelona) ; Espinosa, Cristina (Hospital Clínic i Provincial de Barcelona) ; Guirado, Luis (Institut d'Investigació Biomèdica Sant Pau) ; Budde, K (Charité - Universitätsmedizin Berlin) ; Sommerer, Claudia (Heidelberg University Hospital (Alemanya)) ; Lizana, Ana (Hospital Clínic i Provincial de Barcelona) ; Lopez-Pua, Yolanda (Hospital Clínic i Provincial de Barcelona) ; Brunet, Mercè (Instituto de Salud Carlos III)
Previous results from our group and others have shown that urinary pellet expression of miR155-5p and urinary CXCL-10 production could play a key role in the prognosis and diagnosis of acute rejection (AR) in kidney transplantation patients. [...]
2021 - 10.1371/journal.pone.0245880
PloS one, Vol. 16 Núm. 1 January (january 2021) , p. e0245880  
2.
12 p, 2.3 MB Advantages of plasmatic CXCL-10 as a prognostic and diagnostic biomarker for the risk of rejection and subclinical rejection in kidney transplantation / Millán, O. (Instituto de Salud Carlos III) ; Rovira, J. (Red de Investigación Renal (REDINREN)) ; Guirado, Luis (Institut d'Investigació Biomèdica Sant Pau) ; Espinosa, C. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Budde, K. (Charité - Universitätsmedizin Berlin) ; Sommerer, Claudia (Heidelberg University Hospital (Alemanya)) ; Piñeiro, G.J. (Institut Clínic de Nefrologia i Urologia. Servei de Nefrologia i Trasplantament Renal) ; Diekmann, F. (Institut Clínic de Nefrologia i Urologia. Servei de Nefrologia i Trasplantament Renal) ; Brunet, M. (Instituto de Salud Carlos III)
This study evaluate the potential of plasmatic CXCL-10 (pCXCL-10) as a pre&post transplantation prognostic and diagnostic biomarker of T-cell-mediated rejection (TCMR), antibody-mediated rejection (ABMR) and subclinical rejection (SCR) risk in adult kidney recipients considering BKV and CMV infections as possible clinical confounder factors. [...]
2021 - 10.1016/j.clim.2021.108792
Clinical Immunology, Vol. 229 (august 2021) , p. 108792  
3.
12 p, 2.3 MB Monitoring of gene expression in tacrolimus-treated de novo renal allograft recipients facilitates individualized immunosuppression : results of the IMAGEN study / Sommerer, Claudia (Heidelberg University Hospital (Alemanya)) ; Brunet, M. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Budde, K. (Charité University Hospital Berlin) ; Millán, O. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Guirado, Luis (Institut d'Investigació Biomèdica Sant Pau) ; Glander, P. (Charité University Hospital Berlin) ; Meuer, S. (Institute of Immunology. University Hospital Heidelberg) ; Zeier, M. (Heidelberg University Hospital (Alemanya)) ; Giese, Thomas (Heidelberg University Hospital (Alemanya))
Aims: Calcineurin inhibitors (CNI) have a small therapeutic window, and drug monitoring is required. Pharmacokinetic monitoring does not correlate sufficiently with clinical outcome. Therefore, the expression of nuclear factor of activated T cells (NFAT)-regulated genes in the peripheral blood has been suggested as a potentially useful immune monitoring tool to optimize CNI therapy. [...]
2021 - 10.1111/bcp.14794
British Journal of Clinical Pharmacology, Vol. 87 Núm. 10 (october 2021) , p. 3851-3862  

Vea también: autores con nombres similares
3 Sommerer, Claudia
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.